Estimates of commercial population at high risk for cardiovascular events: impact of aggressive cholesterol reduction.

Fitch, Kathryn; Goldberg, Sara W; Iwasaki, Kosuke; Pyenson, Bruce S; Kuznik, Andreas; Solomon, Henry A

Fitch, Kathryn; Goldberg, Sara W; Iwasaki, Kosuke; Pyenson, Bruce S; Kuznik, Andreas; Solomon, Henry A.

Afiliación

Fitch K; Principal and Healthcare Management Consultant, Ms Goldberg is Consulting Actuary.
Goldberg SW; Consulting Actuary, Milliman, New York, NY.
Iwasaki K; Consulting Actuary, Milliman, New York, NY.
Pyenson BS; Principal and Consulting Actuary, Milliman, New York, NY.
Kuznik A; Associate Director of Outcome Research, Pfizer Global Pharmaceuticals, New York, NY.
Solomon HA; Medical Director, Pfizer Global Pharmaceuticals, New York, NY.

Am Health Drug Benefits ; 2(6): 224-32, 2009 Sep.

Article en En | MEDLINE | ID: mdl-25126293

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Am Health Drug Benefits Año: 2009 Tipo del documento: Article

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google